Evidence map›Paper›PMID 31638466›Full record

ArticleThe Journal of international medical research2019

Nephroprotective effect of losartan in IgA model rat.

Li Xing, Er Lin Song, Xi Bei Jia, Jing Ma, Bing Li, Xu Gao

RetractedAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Li XingDepartment of Nephrology, First Affiliated Hospital of Harbin Medical University, Harbin, P. R. China.ORCID https://orcid.org/0000-0002-4759-7380
Er Lin SongDepartment of Urinary Surgery, First Affiliated Hospital of Harbin Medical University, Harbin, P. R. China.
Xi Bei JiaDepartment of Nephrology, First Affiliated Hospital of Harbin Medical University, Harbin, P. R. China.
Jing MaDepartment of Nephrology, First Affiliated Hospital of Harbin Medical University, Harbin, P. R. China.
Bing LiDepartment of Nephrology, Second Affiliated Hospital of Harbin Medical University, Harbin, P. R. China.
Xu GaoDepartment of Biochemistry and Molecular Biology of Harbin Medical University, Harbin, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ActinsAnimalsChemokine CCL2Disease Models, AnimalGene Expression RegulationGlomerulonephritis, IGAImmunoglobulin AKidneyLiverLosartanMaleNephronsProtective AgentsRats, Sprague-DawleyTransforming Growth Factor beta1UrinalysisActa2 protein, ratActinsCcl2 protein, ratChemokine CCL2Immunoglobulin ALosartanProtective AgentsTransforming Growth Factor beta1angiotensin receptor blockersIgA nephropathyinflammatory factorslosartanMCP1mesangial cellsnephroprotective effectTGF-β1tubulointerstitial injury

Identifiers

PMID31638466
PMCPMC6997782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.